Metastatic Disease in the Cerebellum: The LSU Experience in 1981-1993

    loading  Checking for direct PDF access through Ovid


We retrospectively determined the outcome of management of metastatic disease in the cerebellum (MDC) in 45 patients because MDC is considered to be more immediately life-threatening than metastases in other intracranial locations. Treatment consisted of tumor resection and radiotherapy (RR; n = 11) or of radiotherapy alone (RA; n = 34). Significant differences in the median survival (15 months for RR and 3 months for RA, p = 0.005) and in survival rates at 1 year (61 ± 30% for RR and 9 ± 10% for RA, p < 0.001) and at 2 years (15 ± 22% for RR and 0% for RA, p < 0.05) were noted. This combined management program of surgery followed by radiotherapy for MDC produced a worthwhile gain in survival.

Related Topics

    loading  Loading Related Articles